A Study to Evaluate the Effect of Food on the Pharmacokinetics of the Nemtabrutinib Final Market Formulation 1 (FMF1) in Healthy Male Participants
Latest Information Update: 20 Jan 2025
Price :
$35 *
At a glance
- Drugs Nemtabrutinib (Primary)
- Indications Chronic lymphocytic leukaemia; Follicular lymphoma; Haematological malignancies; Richter's syndrome
- Focus Pharmacokinetics
- Acronyms MK-1026-016
- Sponsors Merck Sharp & Dohme
- 20 Jan 2025 New trial record